Alpha-2-macroglobulin as an equine joint therapeuticByBrenna R. Pugliese, DVM, MS, DACVS (Large Animal)September 9th 2026
Q&A: What a newly published JAVMA study reveals about Librela and a rare condition in dogsByRichard Goldstein, DVM, DACVIM (SAIM), DECVIM-CA,Caitlin McCafferty, Content ProducerAugust 31st 2026
Adequan injections for dogs and horses recalled nationwide after glass fibers detectedByAbi Bautista-Alejandre, Assistant EditorAugust 3rd 2026
Cornell study links cranial shape and body weight to syringomyelia riskByChris Mazzolini, VP, ContentJune 25th 2026